Fluxion Biosciences Inc Product Pipeline Analysis, 2018 Update [Report Updated: 09052018] Prices from USD $750

01:17 EDT 11 Aug 2018 | BioPortfolio Report Blog


Fluxion Biosciences Inc Fluxion is an analytical and live cell analysis tools provider. The company offers IsoFlux Liquid Biopsy System, an instrument designed to enrich rare cell populations such as circulating tumor cells, cancer stem cells and rare immunological cells; IsoFlux cell enrichment kits; IsoFlux downstream analysis kits; and BioFlux consumables and accessories. It provides BioFlux System for live cell analysis under shear flow and IonFlux System for automated patch clamping. Its sequencing assays solutions provide ultrasensitivity mutation detection from CTCs and cellfree DNA. The company serves biotech and pharmaceutical companies, academic institutions and government research organizations. It markets its products through a network of distributors in the US, Australia, New Zealand, China, Spain, France, Germany, Austria, India, Japan and Singapore, among others. Fluxion is headquartered in Alameda, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Fluxion Biosciences Inc

The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research Development strategies

Develop marketentry and market expansion strategies

Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Original Article: Fluxion Biosciences Inc Product Pipeline Analysis, 2018 Update [Report Updated: 09052018] Prices from USD $750


More From BioPortfolio on "Fluxion Biosciences Inc Product Pipeline Analysis, 2018 Update [Report Updated: 09052018] Prices from USD $750"

Quick Search


Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...